Cabot Corporation $CBT Holdings Lowered by Wellington Management Group LLP

Wellington Management Group LLP decreased its stake in Cabot Corporation (NYSE:CBTFree Report) by 32.2% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,416,471 shares of the specialty chemicals company’s stock after selling 1,149,701 shares during the quarter. Wellington Management Group LLP’s holdings in Cabot were worth $219,464,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Empowered Funds LLC acquired a new stake in Cabot during the 2nd quarter worth about $3,147,000. United Capital Financial Advisors LLC acquired a new position in shares of Cabot in the second quarter worth about $590,000. Equitable Holdings Inc. acquired a new position in shares of Cabot in the second quarter worth about $499,000. Jefferies Financial Group Inc. purchased a new position in shares of Cabot in the second quarter worth approximately $383,000. Finally, Corient Private Wealth LP acquired a new stake in shares of Cabot during the second quarter valued at approximately $1,140,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Price Performance

NYSE CBT opened at $83.67 on Monday. The company has a 50 day simple moving average of $87.62 and a 200-day simple moving average of $81.24. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. The firm has a market capitalization of $4.32 billion, a price-to-earnings ratio of 23.57, a price-to-earnings-growth ratio of 10.98 and a beta of 0.84. Cabot Corporation has a 52-week low of $58.33 and a 52-week high of $94.53.

Cabot (NYSE:CBTGet Free Report) last announced its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. The firm had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The firm’s revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Equities research analysts predict that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.

Cabot Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be issued a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot’s payout ratio is currently 53.24%.

Insider Buying and Selling at Cabot

In other news, CEO Sean D. Keohane sold 91,923 shares of the company’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $86.41, for a total value of $7,943,066.43. Following the transaction, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at approximately $34,921,218.94. This represents a 18.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 3.08% of the company’s stock.

Analysts Set New Price Targets

CBT has been the subject of several research analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. JPMorgan Chase & Co. boosted their target price on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research note on Friday, August 7th. UBS Group reduced their target price on Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a report on Wednesday, August 5th. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, August 9th. Finally, Mizuho raised their target price on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, June 25th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cabot has an average rating of “Hold” and a consensus target price of $89.00.

Read Our Latest Stock Analysis on CBT

About Cabot

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Featured Stories

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.